Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Ganoderma lucidum (commonly known as Reishi or Lingzhi) has a long history of use in traditional Chinese medicine for promoting liver health and treating chronic liver diseases, including cirrhosis. Historical texts reference Ganoderma as a “superior herb” thought to detoxify the body, improve vitality, and support liver function. In traditional practice, Ganoderma is often prescribed as a tonic for individuals with various liver complaints, including hepatitis and cirrhosis, with the belief that it can help regenerate liver cells and reduce inflammation.

Scientific evidence, however, is limited and primarily preclinical. Some animal studies and in vitro experiments suggest extracts of Ganoderma may have hepatoprotective properties, such as antioxidant effects, inhibition of hepatic fibrosis, and modulation of immune responses. For example, polysaccharides and triterpenoids isolated from Ganoderma have shown the ability to reduce markers of liver damage and fibrosis in animal models. Nonetheless, there are few well-designed human clinical trials evaluating Ganoderma’s efficacy specifically for cirrhosis. Most available studies are small, not placebo-controlled, or focus on general liver function rather than cirrhosis outcomes.

In summary, while Ganoderma’s use for liver cirrhosis is well-rooted in traditional medicine, current scientific evidence is insufficient to confirm its effectiveness for this specific condition in humans. Further clinical research is needed to validate its therapeutic potential for cirrhosis.

More about ganoderma
More about Cirrhosis of the Liver

Other ingredients used for Cirrhosis of the Liver

Other health conditions supported by ganoderma

Products containing ganoderma